178 related articles for article (PubMed ID: 36788350)
1. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
Ding Y; Chen J; Li S; Wren JD; Bajpai AK; Wang J; Tanaka T; Rice HC; Hays FA; Lu L; Zhang XA
Oncogene; 2023 Mar; 42(12):861-868. PubMed ID: 36788350
[TBL] [Abstract][Full Text] [Related]
2. EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
Wang J; Wren JD; Ding Y; Chen J; Mittal N; Xu C; Li X; Zeng C; Wang M; Shi J; Zhang YH; Han SJ; Zhang XA
Cancer Lett; 2022 Jun; 536():215641. PubMed ID: 35339615
[TBL] [Abstract][Full Text] [Related]
3. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
4. EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.
Fu C; Wang J; Pallikkuth S; Ding Y; Chen J; Wren JD; Yang Y; Wong KK; Kameyama H; Jayaraman M; Munshi A; Tanaka T; Lidke KA; Zhang XA
Cell Mol Life Sci; 2022 Jun; 79(7):389. PubMed ID: 35773608
[TBL] [Abstract][Full Text] [Related]
5. EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.
Stipp CS; Kolesnikova TV; Hemler ME
J Biol Chem; 2001 Nov; 276(44):40545-54. PubMed ID: 11504738
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.
Kolesnikova TV; Kazarov AR; Lemieux ME; Lafleur MA; Kesari S; Kung AL; Hemler ME
Neoplasia; 2009 Jan; 11(1):77-86, 4p following 86. PubMed ID: 19107234
[TBL] [Abstract][Full Text] [Related]
7. Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL.
He B; Zhang YH; Richardson MM; Zhang JS; Rubinstein E; Zhang XA
Biochem J; 2011 Aug; 437(3):399-411. PubMed ID: 21609323
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin-enriched microdomains regulate digitation junctions.
Huang C; Fu C; Wren JD; Wang X; Zhang F; Zhang YH; Connel SA; Chen T; Zhang XA
Cell Mol Life Sci; 2018 Sep; 75(18):3423-3439. PubMed ID: 29589089
[TBL] [Abstract][Full Text] [Related]
9. The immunoglobulin-like superfamily member IGSF3 is a developmentally regulated protein that controls neuronal morphogenesis.
Usardi A; Iyer K; Sigoillot SM; Dusonchet A; Selimi F
Dev Neurobiol; 2017 Jan; 77(1):75-92. PubMed ID: 27328461
[TBL] [Abstract][Full Text] [Related]
10. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.
Charrin S; Le Naour F; Labas V; Billard M; Le Caer JP; Emile JF; Petit MA; Boucheix C; Rubinstein E
Biochem J; 2003 Jul; 373(Pt 2):409-21. PubMed ID: 12708969
[TBL] [Abstract][Full Text] [Related]
11. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
12. IGSF3 mutation identified in patient with severe COPD alters cell function and motility.
Schweitzer KS; Jinawath N; Yonescu R; Ni K; Rush N; Charoensawan V; Bronova I; Berdyshev E; Leach SM; Gillenwater LA; Bowler RP; Pearse DB; Griffin CA; Petrache I
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573489
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin protein contributions to cancer.
Wang HX; Li Q; Sharma C; Knoblich K; Hemler ME
Biochem Soc Trans; 2011 Apr; 39(2):547-52. PubMed ID: 21428937
[TBL] [Abstract][Full Text] [Related]
14. Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F.
Oosterheert W; Xenaki KT; Neviani V; Pos W; Doulkeridou S; Manshande J; Pearce NM; Kroon-Batenburg LM; Lutz M; van Bergen En Henegouwen PM; Gros P
Life Sci Alliance; 2020 Nov; 3(11):. PubMed ID: 32958604
[TBL] [Abstract][Full Text] [Related]
15. The tetraspanin network modulates MT1-MMP cell surface trafficking.
Schröder HM; Hoffmann SC; Hecker M; Korff T; Ludwig T
Int J Biochem Cell Biol; 2013 Jun; 45(6):1133-44. PubMed ID: 23500527
[TBL] [Abstract][Full Text] [Related]
16. Tetraspanins: Spanning from solid tumors to hematologic malignancies.
Yang YG; Sari IN; Zia MF; Lee SR; Song SJ; Kwon HY
Exp Hematol; 2016 May; 44(5):322-8. PubMed ID: 26930362
[TBL] [Abstract][Full Text] [Related]
17. EWI-2 modulates lymphocyte integrin alpha4beta1 functions.
Kolesnikova TV; Stipp CS; Rao RM; Lane WS; Luscinskas FW; Hemler ME
Blood; 2004 Apr; 103(8):3013-9. PubMed ID: 15070678
[TBL] [Abstract][Full Text] [Related]
18. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling.
Berditchevski F; Odintsova E
J Cell Biol; 1999 Jul; 146(2):477-92. PubMed ID: 10427099
[TBL] [Abstract][Full Text] [Related]
19. EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5.
Stipp CS; Kolesnikova TV; Hemler ME
J Cell Biol; 2003 Dec; 163(5):1167-77. PubMed ID: 14662754
[TBL] [Abstract][Full Text] [Related]
20. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.
Fu C; Zhang Q; Wang A; Yang S; Jiang Y; Bai L; Wei Q
Mol Oncol; 2021 May; 15(5):1543-1565. PubMed ID: 33605506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
